Healthcare Industry News: Centinel Spine
News Release - May 11, 2009
Applied Spine Technologies Names New Chief Executive Officer
Craig Corrance Brings over 20 Years of Management Experience in the Global Orthopaedic IndustriesNEW HAVEN, Conn.--(HSMN NewsFeed)--Applied Spine Technologies, Inc. (AST) announced today that Craig Corrance, who has more than 20 years of management experience in global orthopaedic industries, has been named as the company’s new Chief Executive Officer.
Mr. Corrance was formerly the President for Centinel Spine, Inc. Prior to Centinel, Mr. Corrance served in senior executive roles for both U.S. and international orthopaedic and spinal product companies, of particular note Altiva Corporation and Scient’x USA, where he was instrumental in building businesses from start-up positions utilizing his experience of developing and commercializing technologies, fund raising, acquisitions and strategic and operational planning.
Mr. Corrance stated, “This is a tremendously exciting time to join AST, the company has a cohort of patients maturing to a one year follow up with the Stabilimax NZ(R) system, has recently commenced upon a second tranche of patient enrollment and collaborates with a renowned team of surgeons here in the United States”.
“Craig’s arrival extends the momentum that Applied Spine has enjoyed to date. Craig is a key component within the company’s strategic plan and his experience will assist with the positioning of AST as a world leader in motion preservation via dynamic stabilization” said AST Board Director Jeff Barnes.
About Applied Spine Technologies, Inc.
Applied Spine Technologies, Inc. is developing Stabilimax NZ(R), a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion. The Stabilimax NZ(R) is a Dynamic Stabilization System based on the biomechanical principles of the Neutral Zone, pioneered by Manohar Panjabi, PhD. The Stabilimax NZ(R) attempts to stabilize a patient’s lumbar spine while preserving motion. The Stabilimax NZ(R) IDE Clinical Study is underway at selected sites around the US.
For further information, please visit www.legandbackpainstudy.com or, to find a participating surgeon near you, visit www.clinicaltrials.gov and type “Stabilimax NZ” in the search area.
Source: Applied Spine Technologies
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
